Novel chenodeoxycholic acid–sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study

References

• Ajun W, Yan S, Li G, Huili L. Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study. Carbohydr Polym, 2009;75:566–74
   Web of Science ®Google Scholar
• Awasthi R, Kulkarni GT. Development of novel gastroretentive floating particulate drug delivery system of gliclazide. Curr Drug Deliv, 2012;9:437–51
   PubMed Web of Science ®Google Scholar
• Awasthi R, Kulkarni GT. Development of novel gastroretentive drug delivery system of gliclazide: Hollow beads. Drug Dev Ind Pharm, 2014;40:398–408
   PubMed Web of Science ®Google Scholar
• Barnett R. Historical keyword: Diabetes. Lancet, 2010;375:191
   PubMed Web of Science ®Google Scholar
• Bonino CA, Samorezov JE, Jeon O, Alsberg E, Khan SA. Real-time in situ rheology of alginate hydrogel photocrosslinking. Soft Matter, 2011;7:11510–17
   Web of Science ®Google Scholar
• Buckley MM, Goa KL, Price AH, Brogden RN. Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia. Drugs, 1989;37:761–800
   PubMed Web of Science ®Google Scholar
• Chittleborough CR, Grant JF, Phillips PJ, Taylor AW. The increasing prevalence of diabetes in South Australia: The relationship with population ageing and obesity. Public Health, 2007;121:92–9
   PubMed Web of Science ®Google Scholar
• Davignon J. 1990. Probucol revisited. In: Descovich G, Gaddi A, Magri G, Lenzi S, eds. Atherosclerosis and cardiovascular disease. Netherlands: Springer, pp. 449–59
   Google Scholar
• Davignon J. 1994. Probucol, principles and treatment of lipoprotein disorders. Berlin, Heidelberg: Springer, 429--69
   Google Scholar
• de Celis Alonso B, Rayment P, Ciampi E, Ablett S, Marciani L, Spiller RC, Norton IT, Gowland PA. NMR relaxometry and rheology of ionic and acid alginate gels. Carbohydr Polym, 2010;82:663–9
   Web of Science ®Google Scholar
• Draget KI, Taylor C. Chemical, physical and biological properties of alginates and their biomedical implications. Food Hydrocolloids, 2011;25:251–6
   Web of Science ®Google Scholar
• George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan – A review. J Control Release: Official Journal of the Controlled Release Society, 2006;114:1–14
   PubMed Web of Science ®Google Scholar
• Gill P, Moghadam TT, Ranjbar B. Differential scanning calorimetry techniques: Applications in biology and nanoscience. J Biomol Tech, 2010;21:167–93
   PubMedGoogle Scholar
• Gorogawa S, Kajimoto Y, Umayahara Y, Kaneto H, Watada H, Kuroda A, Kawamori D, Yasuda T, Matsuhisa M, Yamasaki Y, Hori M. Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract, 2002;7:1–10
   Web of Science ®Google Scholar
• Heel RC, Brogden RN, Speight TM, Avery GS. Probucol: A review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia. Drugs, 1978;15:409–28
   PubMed Web of Science ®Google Scholar
• Kandrac J, Kevresan S, Gu JK, Mikov M, Fawcett JP, Kuhajda K. Isolation and determination of bile acids. Eur J Drug Metab Pharmacokinetics, 2006;1:157–77
   Google Scholar
• Kuhajda K, Kandrac J, Kevresan S, Mikov M, Fawcett JP. Structure and origin of bile acids: An overview. Eur J Drug Metab Pharmacokinetics, 2006;31:135–43
   PubMed Web of Science ®Google Scholar
• Kulkarni AR, Soppimath KS, Aminabhavi TM, Rudzinski WE. In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads. Eur J Pharm Biopharm, 2001;51:127–33
   PubMed Web of Science ®Google Scholar
• Legrand J, Dumont E, Comiti J, Fayolle F. Diffusion coefficients of ferricyanide ions in polymeric solutions – Comparison of different experimental methods. Electrochim Acta, 2000;45:1791–803
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Sallami HS, Fang Z, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, Matthews V, Arfuso F, et al. Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes. AAPS PharmSciTech, 2015;16:45--52
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Arfuso F, Al-Salami H. Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells. Artif Cells Nanomed Biotechnol, 2014a. [Epub ahead of print]. doi: 10.3109/21691401.2014.934457
   Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Al-Sallami HS, Fang Z, Mukkur T, Mikov M, Golocorbin-Kon S, Fakhoury M, Arfuso F. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterization study. Drug Design Dev Ther, 2014b;8:1003
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Al-Sallami HS, Fang Z, Mukkur T, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, et al. Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol. Drug Design Dev Ther, 2014c;8:1221–30
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, Watts GF, Arfuso F, Al-Salami H. An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer. Drug Design Dev Therm, 2014d;8:1673–83
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, Mukkur T, Mikov M, Lalic-Popovic M, Stojančević M. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: The use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J Pharm Innov, 2014e;9:150–7
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, Mukkur TK, Mikov M, Lalic-Popovic M, Stojancevic M, et al. An advanced microencapsulated system: A platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharm Dev Technol, 2014f. [Epub ahead of print]. doi: 10.3109/10837450.2014.915570
   PubMedGoogle Scholar
• Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, Mukkur TK, Mikov M, Lalic-Popovic M, Stojancevic M, et al. An advanced microencapsulated system: A platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharm Dev Technol, 2014g. [Epub ahead of print]. doi: 10.3109/10837450.2014.915570
   PubMedGoogle Scholar
• Negrulj R, Mooranian A, Al-Salami H. Potentials and limitations of bile acids in type 2 diabetes mellitus: Applications of microencapsulation as a novel oral delivery system. J Endocrinol Diabetes Mellitus, 2013;1:49–59
   Google Scholar
• Pamies R, Schmidt RR, Martínez MdCL, Torre JGdl. The influence of mono and divalent cations on dilute and non-dilute aqueous solutions of sodium alginates. Carbohydr Polym, 2010;80:248–53
   Web of Science ®Google Scholar
• Schmid KL, Schmid LM, Pedersen C. Knowledge of the ocular effects of diabetes among the general population of Australia and the members of Diabetes Australia. Clin Exp Optom, 2003;86:91–103
   PubMedGoogle Scholar
• Schulze MB, Shai I, Manson JE, Li T, Rifai N, Jiang R, Hu FB. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes. Diabetologia, 2004;47:2129–36
   PubMed Web of Science ®Google Scholar
• Shimizu H, Uehara Y, Shimomura Y, Tanaka Y, Kobayashi I. Probucol attenuated hyperglycemia in multiple low-dose streptozotocin-induced diabetic mice. Life Sci, 1991;49:1331–8
   PubMed Web of Science ®Google Scholar
• Suzuki H, Ogawa M, Hironaka K, Ito K, Sunada H. A nifedipine coground mixture with sodium deoxycholate. I. Colloidal particle formation and solid-state analysis. Drug Dev Ind Pharmacy, 2001;27:943–9
   PubMed Web of Science ®Google Scholar
• Takka S, Cali AG. Bile salt-reinforced alginate-chitosan beads. Pharm Dev Technol, 2012;17:23–9
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Inkyo M, Yumoto R, Nagai J, Takano M, Nagata S. Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improve in vitro dissolution and in vivo oral absorption. Drug Dev Ind Pharmacy, 2012;38:1015–23
   PubMed Web of Science ®Google Scholar
• Tanous D, Hime N, Stocker R. Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds. Redox Rep: Commun Free Radical Res, 2008;13:48–59
   PubMed Web of Science ®Google Scholar
• Torpy JM, Lynm C, Glass RM. DIabetes. JAMA, 2009;301:1620
   PubMedGoogle Scholar
• Whelehan M, Marison IW. Microencapsulation using vibrating technology. J Microencapsul, 2011;28:669–88
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Fukuda N, Shiroi S, Shiotsuki Y, Nagata Y, Tani T, Sakai T. Effects of dietary fat levels on the absorption and tissue accumulation of probucol in the rat. Arzneimittel-Forschung, 1994;44:1059–62
   PubMed Web of Science ®Google Scholar
• Yamashita S, Matsuzawa Y. Where are we with probucol: A new life for an old drug? Atherosclerosis, 2009;207:16–23
   PubMed Web of Science ®Google Scholar
• Yang Y, Campanella OH, Hamaker BR, Zhang G, Gu Z. Rheological investigation of alginate chain interactions induced by concentrating calcium cations. Food Hydrocolloids, 2013;30:26–32
   Web of Science ®Google Scholar